References
- Stokes M, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res 2011;11:135
- Marietta M, Facchini L, Pedrazzi P, et al. Pathophysiology of bleeding in surgery. Transplant Proc 2006;38:812-14
- Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010;50:753-65
- Gabay M, Boucher BA. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy 2013;33:935-55
- Wright JD, Ananth CV, Lewin SN, et al. Patterns of use of hemostatic agents in patients undergoing major surgery. J Surg Res 2014;186:458-66
- Food and Drug Administration: Department of Health E, and Welfare. NDA 12159. Silver Spring, MD: Food and Drug Administration: Department of Health, Education, and Welfare, 1959. Available at: http://www.ethicon360.com/sites/default/files/JJ%20Letter.pdf [Last accessed April 30, 2014]
- US Food and Drug Administration. Premarket Approval (PMA). Silver Spring, MD: US Food and Drug Administration, 2014. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm [Last accessed April 30, 2014]
- Ethicon, Inc. a Johnson & Johnson Company. Surgicel Fibrillar Absorbable Hemostat. Somerville, NJ: Ethicon US, LLC, 2014. Available at: http://www.ethicon360.com/products/surgicel-fibrillar-absorbable-hemostat [Last accessed April 30, 2014]
- Ethicon, Inc. a Johnson & Johnson Company. Surgicel SNoW Absorbable Hemostat. Somerville, NJ: Ethicon, US LLC, 2014. Available at: http://www.ethicon360.com/products/surgicel-snow-absorbable-hemostat [Last accessed April 30, 2014]
- Premier, Inc. Mission and vision. Charlotte, NC: Premier, Inc, 2014. Available at: https://www.premierinc.com/wps/portal/premierinc/public/aboutpremier/missionvision [Last accessed May 5, 2014]
- Hutchinson R, George K, Johns D, et al. Hemostatic efficacy and tissue reaction of oxidized regenerated cellulose hemostats. Cellulose 2013;20:537-45
- Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
- Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008;27:2037-49
- Seeger JD, Williams PL, Walker AM. An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf 2005;14:465-76
- Steiner PM, Cook D. Propensity matching and propensity scores. In: Little TD, editor. The Oxford handbook of quantitative methods in psychology. 1. New York: Oxford University Press, 2013
- Ethicon, Inc. a Johnson & Johnson Company. 2014 List prices for Surgicel family of topical absorbable hemostats. Somerville, NJ: Ethicon, Inc; 2014
- Carless PA, Henry DA, Anthony DM. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion. Cochrane Database Syst Rev 2003;2:CD004171